Filgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth

Dec 2020| TBR1181B| TBRC (Publisher)

Sample Report

Report Highlights

Including: By Application: Oncology; Chronic and Autoimmune Diseases; Blood Disorders; Growth Hormone Deficiency; Others
By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Covering: Teva Pharmaceutical Industries Ltd.; Novartis International AG; Biocon Limited; Intas Biopharmaceuticals; Dr. Reddy's Laboratories

Filgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global Filgrastim Biosimilars market.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Identify growth segments for investment.
Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
Create regional and country strategies on the basis of local data and analysis.
Stay abreast of the latest customer and market research findings
Benchmark performance against key competitors.
Develop strategies based on likely future developments.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the Filgrastim Biosimilars market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global Filgrastim Biosimilars market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
Report Structure – This section gives the structure of the report and the information covered in the various sections.
Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by game type, and by device.
Market Characteristics – The market characteristics section of the report defines and explains the filgrastim biosimilars market. This chapter also defines and describes goods and related services covered in the report.
Trends And Strategies – This chapter describes the major trends shaping the global filgrastim biosimilars market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
COVID Impact Analysis – This section provides an insight on how the pandemic is impacting the filgrastim biosimilars market.
Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional Analysis – This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
Regional Market Size and Growth – This section contains the region’s market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
Competitive Landscape – This section covers details on the competitive landscape of the global filgrastim biosimilars market, estimated market shares and company profiles for the leading players.
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for filgrastim biosimilars companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global filgrastim biosimilars market is segmented into –

By Application: Oncology; Chronic and Autoimmune Diseases; Blood Disorders; Growth Hormone Deficiency; Others
By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Novartis International AG; Biocon Limited; Intas Biopharmaceuticals; Dr. Reddy's Laboratories

Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia.

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table 1 : Global Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 2 : Global Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 3 : Global Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 4 : Global Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 5 : Global Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 6 : Global Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 7 : Global Filgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 8 : Global Filgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 9 : Global Filgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 10 : Global Filgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 11 : Asia Pacific Cancer Prevalence, Estimated Average Expenditure, 2019, $
Table 12 : Asia-Pacific Per Capita Healthcare Expenditure, 2015-2019, $
Table 13 : Asia-Pacific Per Capita Net Disposable Income, 2015-2019, $
Table 14 : Asia Pacific Population By Age Group, 2015-2023, Thousands
Table 15 : Asia-Pacific Biologics Market Size, 2015-2019, $ Billion
Table 16 : Asia-Pacific Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 17 : Asia-Pacific Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 18 : Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 19 : Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 20 : Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 21 : Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 22 : China Cancer Prevalence, Estimated Average Expenditure, 2019, $
Table 23 : China Per Capita Healthcare Expenditure, 2015-2019, $
Table 24 : China Per Capita Net Disposable Income, 2015-2019, $
Table 25 : China Population By Age Group, 2015-2023, Thousands
Table 26 : China Biologics Market Size, 2015-2019, $ Billion
Table 27 : China Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 28 : China Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 29 : China Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 30 : China Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 31 : China Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 32 : China Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 33 : India Cancer Prevalence, Estimated Average Expenditure, 2019, $
Table 34 : India Per Capita Healthcare Expenditure, 2015-2019, $
Table 35 : India Per Capita Net Disposable Income, 2015-2019, $
Table 36 : India Population By Age Group, 2015-2023, Thousands
Table 37 : India Biologics Market Size, 2015-2019, $ Billion
Table 38 : India Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 39 : India Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 40 : India Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 41 : India Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 42 : India Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 43 : India Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 44 : Japan Cancer Prevalence, Estimated Average Expenditure, 2019, $
Table 45 : Japan Per Capita Healthcare Expenditure, 2015-2019, $
Table 46 : Japan Per Capita Net Disposable Income, 2015-2019, $
Table 47 : Japan Population By Age Group, 2015-2023, Thousands
Table 48 : Japan Biologics Market Size, 2015-2019, $ Billion
Table 49 : Japan Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 50 : Japan Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 51 : Japan Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 52 : Japan Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 53 : Japan Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 54 : Japan Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 55 : Australia Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 56 : Australia Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 57 : Australia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 58 : Australia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 59 : Australia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 60 : Australia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 61 : Indonesia Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 62 : Indonesia Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 63 : Indonesia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 64 : Indonesia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 65 : Indonesia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 66 : Indonesia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 67 : South Korea Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 68 : South Korea Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 69 : South Korea Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 70 : South Korea Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 71 : South Korea Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 72 : South Korea Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 73 : Western Europe Estimated Average Expenditure, Cancer Prevalence, 2019
Table 74 : Western Europe Per Capita Healthcare Expenditure, 2015-2019, $
Table 75 : Western Europe Per Capita Net Disposable Income, 2015-2019, $
Table 76 : Western Europe Population By Age Group, 2015-2023, Thousands
Table 77 : Western Europe Biologics Market Size, 2015-2019, $ Billion
Table 78 : Western Europe Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 79 : Western Europe Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 80 : Western Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 81 : Western Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 82 : Western Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 83 : Western Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 84 : UK Estimated Average Expenditure, Filgrastim Biosimilar Market, Cancer Prevalence, 2019
Table 85 : UK Per Capita Healthcare Expenditure, 2015-2019, $
Table 86 : UK Per Capita Net Disposable Income, 2015-2019, $
Table 87 : UK Population By Age Group, 2015-2023, Thousands
Table 88 : UK Biologics Market Size, 2015-2019, $ Billion
Table 89 : UK Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 90 : UK Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 91 : UK Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 92 : UK Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 93 : UK Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 94 : UK Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 95 : Germany Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 96 : Germany Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 97 : Germany Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 98 : Germany Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 99 : Germany Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 100 : Germany Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 101 : France Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 102 : France Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 103 : France Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 104 : France Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 105 : France Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 106 : France Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 107 : Eastern Europe Estimated Average Expenditure, Filgrastim Biosimilar Market, Cancer Prevalence, 2019
Table 108 : Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $
Table 109 : Eastern Europe Population By Age Group, 2015-2023, Thousands
Table 110 : Eastern Europe Per Capita Net Disposable Income, 2015-2019, $
Table 111 : Eastern Europe Biologics Market Size, 2015-2019, $ Billion
Table 112 : Eastern Europe Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 113 : Eastern Europe Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 114 : Eastern Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 115 : Eastern Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 116 : Eastern Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 117 : Eastern Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 118 : Russia Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 119 : Russia Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 120 : Russia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 121 : Russia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 122 : Russia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 123 : Russia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 124 : North America Estimated Average Expenditure, Filgrastim Biosimilar Market, Cancer Prevalence, 2019
Table 125 : North America Per Capita Healthcare Expenditure, 2015-2019, $
Table 126 : North America Per Capita Net Disposable Income, 2015-2019, $
Table 127 : North America Population By Age Group, 2015-2023, Thousands
Table 128 : North America Biologics Market Size, 2015-2019, $ Billion
Table 129 : North America Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 130 : North America Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 131 : North America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 132 : North America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 133 : North America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 134 : North America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 135 : USA Estimated Average Expenditure, Filgrastim Biosimilar Market, Cancer Prevalence, 2019
Table 136 : USA Per Capita Healthcare Expenditure, 2015-2019, $
Table 137 : USA Per Capita Net Disposable Income, 2015-2019, $
Table 138 : USA Market, Population By Age Group, 2015-2023, Thousands
Table 139 : USA Biologics Market Size, 2015-2019, $ Billion
Table 140 : USA Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 141 : USA Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 142 : USA Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 143 : USA Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 144 : USA Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 145 : USA Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 146 : South America Estimated Average Expenditure, Filgrastim Biosimilar Market, Cancer Prevalence, 2019
Table 147 : South America Per Capita Healthcare Expenditure, 2015-2019, $
Table 148 : South America Population By Age Group, 2015-2023, Thousands
Table 149 : South America Per Capita Net Disposable Income, 2015-2019, $
Table 150 : South America Biologics Market Size, 2015-2019, $ Billion
Table 151 : South America Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 152 : South America Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 153 : South America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 154 : South America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 155 : South America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 156 : South America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 157 : Brazil Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 158 : Brazil Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 159 : Brazil Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 160 : Brazil Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 161 : Brazil Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 162 : Brazil Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 163 : Middle East Per Capita Healthcare Expenditure, 2015-2019, $
Table 164 : Middle East Per Capita Net Disposable Income, 2015-2019, $
Table 165 : Middle East Population By Age Group, 2015-2023, Thousands
Table 166 : Middle East Biologics Market Size, 2015-2019, $ Billion
Table 167 : Middle East Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 168 : Middle East Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 169 : Middle East Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 170 : Middle East Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 171 : Middle East Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 172 : Middle East Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 173 : Africa Per Capita Healthcare Expenditure, 2015-2019, $
Table 174 : Africa Per Capita Net Disposable Income, 2015-2019, $
Table 175 : Africa Population By Age Group, 2015-2023, Thousands
Table 176 : Africa Biologics Market Size, 2015-2019, $ Billion
Table 177 : Africa Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Table 178 : Africa Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Table 179 : Africa Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 180 : Africa Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 181 : Africa Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Table 182 : Africa Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
Table 183 : Global Filgrastim Biosimilars Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
Table 184 : Teva Pharmaceutical Industries Ltd.- Financial Performance, 2015 - 2019, $ Billion
Table 185 : Novartis International AG - Financial Performance, 2015 - 2019, $ Billion
Table 186 : Biocon Limited - Financial Performance, 2015 - 2019, $ Billion
Table 187 : Dr. Reddy's Laboratories - Financial Performance, 2015 - 2019, $ Billion
Table 188 : Global Filgrastim Biosimilars Market Size Gain ($ Million), 2019 - 2023, By Country
Table 189 : Global Filgrastim Biosimilars Market Size Gain ($ Million), Segmentation By Application, 2019 - 2023
Table 190 : Global Filgrastim Biosimilars Market Size Gain ($ Million), Segmentation By Distribution Channel, 2019 - 2023
Table 191 : Filgrastim Biosimilars Market Data Sources

Figure 1 : Global Filgrastim Biosimilars Market Segmentation By Application
Figure 2 : Global Filgrastim Biosimilars Market Segmentation By Distribution Channel
Figure 3 : Global Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 4 : Global Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 5 : Global Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 6 : Global Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 7 : Global Filgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 8 : Global Filgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 9 : Asia-Pacific Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 10 : Asia-Pacific Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 11 : Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 12 : Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 13 : China Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 14 : China Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 15 : China Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 16 : China Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 17 : India Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 18 : India Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 19 : India Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 20 : India Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 21 : Japan Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 22 : Japan Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 23 : Japan Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 24 : Japan Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 25 : Australia Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 26 : Australia Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 27 : Australia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 28 : Australia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 29 : Indonesia Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 30 : Indonesia Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 31 : Indonesia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 32 : Indonesia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 33 : South Korea Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 34 : South Korea Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 35 : South Korea Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 36 : South Korea Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 37 : Western Europe Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 38 : Western Europe Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 39 : Western Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 40 : Western Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 41 : UK Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 42 : UK Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 43 : UK Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 44 : UK Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 45 : Germany Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 46 : Germany Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 47 : Germany Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 48 : Germany Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 49 : France Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 50 : France Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 51 : France Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 52 : France Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 53 : Eastern Europe Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 54 : Eastern Europe Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 55 : Eastern Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 56 : Eastern Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 57 : Russia Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 58 : Russia Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 59 : Russia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 60 : Russia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 61 : North America Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 62 : North America Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 63 : North America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 64 : North America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 65 : USA Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 66 : USA Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 67 : USA Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 68 : USA Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 69 : South America Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 70 : South America Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 71 : South America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 72 : South America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 73 : Brazil Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 74 : Brazil Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 75 : Brazil Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 76 : Brazil Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 77 : Middle East Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 78 : Middle East Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 79 : Middle East Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 80 : Middle East Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 81 : Africa Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
Figure 82 : Africa Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
Figure 83 : Africa Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 84 : Africa Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
Figure 85 : Global Filgrastim Biosimilars Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
Figure 86 : Teva Pharmaceutical Industries Ltd. - Financial Performance, 2015 - 2019, $ Billion
Figure 87 : Novartis International AG - Financial Performance, 2015 - 2019, $ Billion
Figure 88 : Biocon Limited - Financial Performance, 2015 - 2019, $ Billion
Figure 89 : Dr. Reddy's Laboratories - Financial Performance, 2015 - 2019, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Filgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth

Report Highlights

FAQ